Cytokinetics sec filings
WebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving … WebPipeline - Cytokinetics A pipeline powered by passion pipeline Research Pre-Clinical Phase 1 Phase 2 Phase 3 CARDIAC MUSCLE Omecamtiv Mecarbil (Heart Failure) Aficamten (oHCM) Aficamten (nHCM) CK-136 (Heart Failure, other) CK-586 SKELETAL MUSCLE Reldesemtiv (ALS) Additional Skeletal Muscle Activators Other Muscle Biology …
Cytokinetics sec filings
Did you know?
WebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and … WebMay 16, 2024 · EX-99.1 CYTOKINETICS AND ROYALTY PHARMA ANNOUNCE $100 MILLION TRANSACTION FOR OMECAMTIV MECARBIL Royalty Pharma Buys 4.5 …
WebMay 16, 2024 · CYTK SEC Filings - Cytokinetics, Inc. - Annual Report, Proxy Statement, Prospectus. ... SEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), … WebMar 31, 2024 · Latest SEC filings for Cytokinetics, Incorporated (CYTK). Latest SEC filings for Cytokinetics, Incorporated (CYTK) Seeking Alpha Seeking Alpha - Go to …
WebFeb 22, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.
WebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th …
greg feder grown upsWebMar 3, 2024 · Fri., March 3, 2024 MarketBeat Logos Global Management LP cut its holdings in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 2.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). greg fathers real estateWebOn February 2, 2024, Cytokinetics also issued a press release announcing Cytokinetics entry into the Royalty Agreement. A copy of the press release is filed as Exhibit 99.1 to … greg feith biographyWebApr 8, 2024 · Cytokinetics Inc (CYTK) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Tuesday, May 10, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), … greg feith bioWebJan 9, 2024 · Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. Here you'll find links to a complete list of filings available through EDGAR and instructions for searching the … greg feith podcastWebUnder the Securities Exchange Act of 1934 (AMENDMENT NO. 1) CYTOKINETICS, INCORPORATED (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER … greg feith divorcedWebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... SEC Filings. GlobeNewswire ... greg feith ties